The findings that Smyd3 is substantially upregulated in most CRCs [54], HCCs [55], and breast cancer tissues [51] support a paradigm in which aberrant expression of chromatin-modifying enzymes, leading to a disturbance in established epigenetic patterns, can ultimately result in tumorigenesis. This evidence concerns the gene SMYD3 and breast cancer.